NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines
Greater Glasgow and Clyde Medicines
Posted: November 20, 2017.
Category - Medicines Update
New Adult NHSGGC Guidelines now available on StaffNet
Posted: November 20, 2017.
Category - Medicines Update
Drug Safety Update (October 2017) includes: Methylprednisolone injectable medicine contai...
Posted: November 20, 2017.
Category - Medicines Update
The Shared Care Agreement (SCA) for melatonin use in children with sleep disturbance has been reviewed and updated to reflect a change in preferred product, with a move away from Bio-melatonin® tablets as a result of recent national effecti...
Posted: November 20, 2017.
Category - Medicines Update Acute
The Therapeutics Handbook content has now been updated and includes the following main changes: Drug Overdose and Toxicity - changes to the
Posted: November 08, 2017.
Category - Medicines Update Primary Care
Tagged with - Opioids Diabetes NSAIDs Formulary MHRA Drug Safety Update Shortages
To view this bulletin in PDF format please click here
This bulletin contains information on:
Posted: November 01, 2017.
Category - Medicines Update
Please remember to download the new BNF app. The old NICE BNF app is not being updated and will be withdrawn at the end of November. The new BNF app can be downloaded from the App Store for iOS devices, and Google Play for Android devices....
Posted: October 30, 2017.
Category - Formulary Update
This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.
For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary.
Posted: October 27, 2017.
Category - Medicines Update
Immune checkpoint inhibitors are a relatively new class of cancer medicine. They can only be prescribed by cancer specialists, however, GP’s and non-cancer specialists should have an awareness of their unique spectrum of side effects an...
Posted: October 25, 2017.
Category - Medicines Update
Changes have been made to the recommendations on interchangeability of oral mesalazine preparations. The BNF now states that there is no evidence to show that any one oral preparation of mesalazine is more effective than another for ulcerative ...
Posted: October 25, 2017.
Category - Medicines Update
What’s new?The interactions section in the BNF and BNF for Children (BNFC) is changing. Print copies of BNF 74 and BNFC 2017-18 have the new format and digital versions (Medicines Complete and the new ...